Van Oirschot M, Bergman A, Verbakel WFAR, Ward L, et al. Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial. Int J Radiat Oncol Biol Phys 2022;114:1016-1021.
PMID: 35031340